Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -1002.90% is in line with its 5-year average of -1019.70%, near the high end of its 5-year range (-206187.50%–57.35%).
97.78% above its 12-month average of -45178.73%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1752.61%.
OPERATING MARGIN
-1002.90%
OPERATING MARGIN AVG TTM
-45178.73%
OPERATING MARGIN AVG 3Y
-2122.56%
OPERATING MARGIN AVG 5Y
-1019.70%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+97.78%
CURRENT VS 3Y AVG
+52.75%
CURRENT VS 5Y AVG
+1.65%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
NewAmsterdam Pharma Company N.V.
Market Cap
$2.60B
Operating Margin
-1002.90%
TTM Avg
-45178.73%
3Y Avg
-2122.56%
5Y Avg
-1019.70%
Market Cap
$2.61B
Operating Margin
-2.49%
TTM Avg
-0.71%
3Y Avg
2.88%
5Y Avg
6.41%
Market Cap
$2.60B
Operating Margin
-274.57%
TTM Avg
-464.41%
3Y Avg
-382.79%
5Y Avg
-92575.80%
Market Cap
$2.56B
Operating Margin
1.90%
TTM Avg
1.29%
3Y Avg
0.61%
5Y Avg
-2.83%
Market Cap
$2.66B
Operating Margin
11.12%
TTM Avg
10.91%
3Y Avg
6.08%
5Y Avg
-3.97%
Market Cap
$2.69B
Operating Margin
-1100.78%
TTM Avg
-2270.51%
3Y Avg
-1606.24%
5Y Avg
-1223.21%
Market Cap
$2.70B
Operating Margin
10.06%
TTM Avg
14.13%
3Y Avg
15.87%
5Y Avg
13.57%
Market Cap
$2.71B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.49B
Operating Margin
-5.13%
TTM Avg
3.60%
3Y Avg
3.31%
5Y Avg
10.24%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NewAmsterdam Pharma Company N.V. (NAMS) | $2.60B | -1002.90% | -45178.73% | -2122.56% | -1019.70% |
| Neogen Corporation (NEOG)vs › | $2.61B | -2.49% | -0.71% | 2.88% | 6.41% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.60B | -274.57% | -464.41% | -382.79% | -92575.80% |
| Privia Health Group, Inc. (PRVA)vs › | $2.56B | 1.90% | 1.29% | 0.61% | -2.83% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.66B | 11.12% | 10.91% | 6.08% | -3.97% |
| Precigen, Inc. (PGEN)vs › | $2.69B | -1100.78% | -2270.51% | -1606.24% | -1223.21% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.70B | 10.06% | 14.13% | 15.87% | 13.57% |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.71B | 0.00% | 0.00% | 0.00% | 0.00% |
| Supernus Pharmaceuticals, Inc. (SUPN)vs › | $2.49B | -5.13% | 3.60% | 3.31% | 10.24% |
| AtriCure, Inc. (ATRC)vs › | $2.73B | 2.44% | -4.62% | -7.21% | -5.02% |
Gross Margin
92.2%
Operating Margin
-1002.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -1752.61% |
| 2026-03-31 | -1921.71% |
| 2025-12-31 | -206187.50% |
| 2025-09-30 | -15845.69% |
| 2025-06-30 | -186.13% |
| 2025-03-31 | -2314.47% |
| 2024-12-31 | -338.47% |
| 2024-09-30 | -85.89% |
| 2024-06-30 | -2306.93% |
| 2024-03-31 | -3922.27% |
| 2023-12-31 | -6360.40% |
| 2023-09-30 | -1685.07% |
| 2023-06-30 | -2474.20% |
| 2023-03-31 | -461.85% |
| 2022-12-31 | -509.88% |
| 2022-09-30 | -509.88% |
| 2022-06-30 | 57.35% |
| 2022-03-31 | 57.35% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
